Last updated: Oct 7, 2026, 12:00 AM

Kordellos Ch. Bros S.A Exchange (AT, EUR)

KORDE.AT

0.42
+0.00 (+0.47%)
Basic MaterialsSteel
Invest Today
Invest Today
1 year return (CAGR)
-11.27%
3 year return (CAGR)
-9.32%
5 year return (CAGR)
-2.69%
10 year return (CAGR)
3.58%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
9.02M
Price/Sales
0.35
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
60.65%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open0.41
Daily high0.43
Daily low0.41
Daily Volume2K
All-time high5.06
1y analyst estimate-
Beta0.42
EPS (TTM)-
Dividend per share0.00
Ex-div date6 Sep 2022
Next earnings date-

Ready to capitalize on Kordellos Ch. Bros S.A's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
KORDE.ATS&P500
Current price drop from All-time high-91.60%-1.06%
Highest price drop-97.43%-56.47%
Date of highest drop25 Aug 20159 Mar 2009
Avg drop from high-87.72%-10.67%
Avg time to new high665 days12 days
Max time to new high6634 days1805 days
News
WHIPPANY, N.J., October 08, 2026--Bayer today announced a partnership with actress and menopause advocate Melissa Joan Hart to increase awareness about Lynkuet® (elinzanetant) 60mg capsules, Bayer’s F...
October 8, 2026
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of inco...
October 8, 2026
Ahead of the openings of Frieze London and Art Basel Paris, Artprice announces the publication of its 33rd annual Contemporary Art Market Report, examining a market undergoing profound change.
October 8, 2026
135-Page Report Tracks Bayer and Merck's ADEMPAS (Riociguat) as the Leading Therapy as Combination Regimens and Balloon Pulmonary Angioplasty Reshape CTEPH TreatmentDublin, Oct. 08, 2026 (GLOBE NEWSWI...
October 8, 2026
Investing.com - The U.S. Food and Drug Administration accepted Bayer’s supplemental New Drug Application for Kerendia (finerenone) to treat adults with chronic kidney disease without diabetes, the com...
October 8, 2026
Today, Schouw & Co. hosts a Capital Markets Day in Copenhagen, Denmark. The Capital Markets Day will focus, among other things, on the continued strength of the conglomerate model following the succes...
October 8, 2026
NYKÖPING, SE / ACCESS Newswire / October 8, 2026 / (STO:CTT) - CTT Systems' Interim Report for Q3 2026 will be published on October 27, 2026, at 08.00 (CET) * The presentation will be webcasted at 09:...
October 8, 2026
BRUSSELS, October 08, 2026--Toshiba Global Commerce Solutions successfully deploys ELERA® Self Service and full self-checkout system across Colruyt Group stores in Belgium.
October 8, 2026
Jim Cramer sees one clear winner from Corteva, Inc. (NYSE:CTVA) latest breakup. During the October 2 episode of Mad Money, Cramer said he would be comfortable building a position in Vylor Inc. (NYSE:V...
October 8, 2026